// App-Quantinova.ai

: RNA-sequencing to identify three different molecular grades and immune checkpoint cascades with distinct clinical behaviour in NMIBC.

Researchers

Presenter

  • Thenappan Chandrasekar

Principal Investigators

  • Jess Shen

  • Aidan Noon

  • Haiyan Jiang

  • Annette Erlich

  • Cynthia Kuk

  • Ruoyu Ni

  • Balram Sukhu

  • Kin Chan

  • Morgan Roupret

  • Thomas Seisen

  • Eva Comperat

  • Joan Sweet

  • Girish S. Kulkarni

  • Neil Eric Fleshner

  • Azar Azad

  • Theodorus van der Kwast

  • Jeff L Wrana

Medical Centers

  • University of Toronto, Toronto, ON, Canada

  • Mount Sinai Hospital, Toronto, ON, Canada

  • The Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • University of Toronto Mount Sinai Hospital and University Health Network, Toronto, ON, Canada

  • The Lunenfeld-Tanenbaum Research Institute, Toronto, Ontario, Canada

  • Gruope Hospitalier Pitie-Salpetriere, Paris, France

  • Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA

  • Salpetriere Hospital, Paris, France

  • Universtiy Health Network, Toronto, ON, Canada

  • Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • University Health Network, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • Programmed cell death protein 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved